review article | Q7318358 |
scholarly article | Q13442814 |
P433 | issue | 2 | |
P304 | page(s) | 1-24 | |
P577 | publication date | 1994-02-01 | |
P1433 | published in | NIH consensus statement | Q27710079 |
P1476 | title | Effect of corticosteroids for fetal maturation on perinatal outcomes | |
P478 | volume | 12 |
Q90165721 | A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events |
Q37542495 | A conference report on prenatal corticosteroid use in low- and middle-income countries |
Q36929650 | A multi-faceted intervention including antenatal corticosteroids to reduce neonatal mortality associated with preterm birth: a case study from the Guatemalan Western Highlands |
Q35571976 | A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial |
Q24657730 | Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death |
Q48276018 | American Pediatric Society's 2016 John Howland Award acceptance lecture: every newborn matters-progress and promise |
Q36772361 | Antenatal Betamethasone for Women at Risk for Late Preterm Delivery |
Q26769708 | Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis |
Q35782249 | Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
Q36335225 | Antenatal corticosteroids trial in preterm births to increase neonatal survival in developing countries: study protocol. |
Q34021240 | Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial |
Q28073792 | Antenatal steroids for fetal lung maturity: Time to target more frequent doses to fewer women? |
Q36717004 | Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes. |
Q24613198 | Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth |
Q33929297 | Antenatal steroids: miracle drug for preemies |
Q42651617 | Appropriate use of antenatal corticosteroid prophylaxis |
Q36436975 | Birth Prevalence of Cerebral Palsy: A Population-Based Study |
Q30558004 | Born too soon: care during pregnancy and childbirth to reduce preterm deliveries and improve health outcomes of the preterm baby |
Q35872209 | Changes in maternal glucose metabolism after the administration of dexamethasone for fetal lung development |
Q26772087 | Current Concepts in the Management of Congenital Diaphragmatic Hernia in Infants |
Q41712100 | Detection and risk stratification of women at high risk of preterm birth in rural communities near Nagpur, India |
Q33783940 | Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep. |
Q37359878 | Dexamethasone intravitreal implant for diabetic macular edema in a pregnant patient |
Q30543140 | Dopaminergic modulation of affective and social deficits induced by prenatal glucocorticoid exposure |
Q92948513 | Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques |
Q35788063 | Drug transfer and metabolism by the human placenta. |
Q33599416 | Effect of antenatal corticosteroid and antibiotics in pregnancies complicated by premature rupture of membranes between 24 and 28 weeks of gestation |
Q36095667 | Effects of prophylactic indomethacin in extremely low-birth-weight infants with and without adequate exposure to antenatal corticosteroids |
Q34585150 | Fetal pharmacotherapy |
Q37542684 | Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during Bronchopulmonary Dysplasia |
Q30445296 | Glucocorticoid programing of the mesopontine cholinergic system |
Q37670441 | Glycemic management after antenatal corticosteroid therapy |
Q34074398 | Induced Innovation and Social Inequality: Evidence from Infant Medical Care |
Q37572261 | Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum. |
Q36184118 | Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial |
Q37256991 | Long-term outcome of preterm infants and the role of neuroimaging |
Q34383222 | Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. |
Q88495108 | Neonatal Morbidities among Moderately Preterm Infants with and without Exposure to Antenatal Corticosteroids |
Q90423523 | Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study |
Q37635926 | Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage |
Q37670662 | PURLs: Steroids during late preterm labor: Better later than never |
Q37175692 | Plasma and renal renin concentrations in adult sheep after prenatal betamethasone exposure |
Q94400186 | Postnatal corticosteroids for transient tachypnea of the newborn |
Q90375041 | Postnatal corticosteroids for transient tachypnoea of the newborn |
Q33709248 | Prenatal betamethasone does not affect glutamatergic or GABAergic neurogenesis in preterm newborns |
Q34524486 | Prenatal corticosteroid impact on hippocampus: implications for postnatal outcomes. |
Q24810958 | Retinopathy of prematurity and risk factors: a prospective cohort study |
Q37382804 | Survival rate of extremely low birth weight infants and its risk factors: case-control study in Japan |
Q47714874 | The Joint Effects of Antenatal Steroids and Gestational Age on Improved Outcomes in Neonates |
Q34586693 | The changing risk of infant mortality by gestation, plurality, and race: 1989-1991 versus 1999-2001 |
Q34085779 | The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair |
Q90197758 | The impact of artificial intelligence in the diagnosis and management of glaucoma |
Q34982748 | The probability of neonatal respiratory distress syndrome as a function of gestational age and lecithin/sphingomyelin ratio |
Q37088729 | Ureaplasma colonization of amniotic fluid and efficacy of antenatal corticosteroids for preterm lung maturation in sheep |
Q24548284 | Vaginal birth after cesarean in California: before and after a change in guidelines |
Q38820342 | What we have learned about antenatal corticosteroid regimens |